Marcelo Kugelmas

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Cytokines and Nash: A Pilot Study of the Effects of Lifestyle Modification and Vitamin E

Marcelo Kugelmas, Daniell B. Hill, Beverly Vivian et al. · Hepatology · 2003 · 505 citations · Full text

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Stephen A. Harrison, Mary E. Rinella, Manal F. Abdelmalek et al. · The Lancet · 2018 · 404 citations

Hepatology, Medicine, Liver Physiology +5

Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy†

Gregory T. Everson, James F. Trotter, Lisa Forman et al. · Hepatology · 2005 · 358 citations